Dr. Viskochil is Division Chief for Medical Genetics at the University of Utah. He is Medical Director for the University of Utah Genetics Counselor Training Program and Director of the Medical Genetics Training Program at the University of Utah. He serves as the Director of the Prader-Willi Syndrome Clinic at the University of Utah. He oversees care of MPS (mucopolysaccharidosis) Disorders at the University of Utah and serves on the International Board of Advisors for the MPS I Registry. His early career focus was devoted to NF1 (neurofibromatosis type 1) related issues, and he served as Chair of the Clinical Care Advisory Board for the Children's Tumor Foundation for over a decade. His research focus has shifted to the implementation of clinical trials for rare disorders. He chairs the Utah Department of Health Newborn Screening Advisory Committee and he is a member of the Utah Rare Disease Advisory Council (Utah RDAC).

Dr. Viskochil serves on the ACMG Advocacy and Government Affairs Committee. His purpose in volunteering to serve with members of this committee is to diminish the disparity in access to genetics services in our country. The disparity of health care services in America due to lack of insurance coverage can be modified by adoption of protocols promulgated through Congress and federal agencies. Implementation of such policies for delivery of genetics-based health care services by state legislatures is one step to ensure fair access to both diagnosis and management of conditions with genetic etiologies.